Hormone Therapy and Factors Affecting Fertility of Women Under 50-Year-Old with Breast Cancer
Mehdi Moradinazar,1 Behjat Marzbani,2 Karoon Shahebrahimi,3 Sara Shahabadi,2 Behnaz Marzbani,4 Zeinab Moradinazar5 1Research Center for Environmental Determinants of Health, School of Public Health, Kermanshah University of Medical Sciences, Kermanshah, Iran; 2Health Education and Promotion Group, V...
Guardado en:
Autores principales: | Moradinazar M, Marzbani B, Shahebrahimi K, Shahabadi S, Moradinazar Z |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eeda374bd15446679a920c24451a3532 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
por: Alfredo Rossi, et al.
Publicado: (2021) -
Hormone-Replacement Therapy and Its Association with Breast Cancer Subtypes: A Large Retrospective Cohort Study
por: Rosenberg V, et al.
Publicado: (2021) -
Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study
por: Wako Z, et al.
Publicado: (2021) -
Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience
por: Irina V. Kolyadina, et al.
Publicado: (2020) -
PI3Kinase Inhibition in Hormone Receptor-Positive Breast Cancer
por: Ajay Dhakal, et al.
Publicado: (2021)